BIO-TECHNE Corp Quarterly Liabilities, Current in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
BIO-TECHNE Corp quarterly Liabilities, Current history and growth rate from Q2 2010 to Q3 2024.
  • BIO-TECHNE Corp Liabilities, Current for the quarter ending September 30, 2024 was $142M, a 11.3% increase year-over-year.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $142M +$14.4M +11.3% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $159M +$30.9M +24% Jun 30, 2024 10-Q 2024-11-05
Q1 2024 $150M +$8.66M +6.13% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $135M +$6.84M +5.32% Dec 31, 2023 10-Q 2024-02-07
Q3 2023 $128M -$9.88M -7.18% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $129M -$47.5M -27% Jun 30, 2023 10-K 2024-08-22
Q1 2023 $141M -$25.7M -15.4% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $128M -$26.4M -17.1% Dec 31, 2022 10-Q 2023-02-07
Q3 2022 $138M +$3.64M +2.71% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $176M +$23.7M +15.6% Jun 30, 2022 10-K 2023-08-23
Q1 2022 $167M +$29.2M +21.2% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $155M +$37.2M +31.7% Dec 31, 2021 10-Q 2022-02-07
Q3 2021 $134M +$28.6M +27.1% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $152M +$45.6M +42.8% Jun 30, 2021 10-K 2022-08-24
Q1 2021 $138M +$32.7M +31.1% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $118M +$12.6M +12% Dec 31, 2020 10-Q 2021-02-08
Q3 2020 $105M +$17.2M +19.4% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $107M +$4.68M +4.59% Jun 30, 2020 10-K 2021-08-25
Q1 2020 $105M +$6.94M +7.08% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $105M +$17.5M +20% Dec 31, 2019 10-Q 2020-02-06
Q3 2019 $88.3M +$4.83M +5.78% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $102M +$22.5M +28.3% Jun 30, 2019 10-K 2020-08-26
Q1 2019 $98M +$27.2M +38.3% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $87.4M -$24.2M -21.7% Dec 31, 2018 10-Q 2019-02-07
Q3 2018 $83.4M -$23.6M -22% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $79.5M -$56M -41.3% Jun 30, 2018 10-K/A 2019-11-06
Q1 2018 $70.9M -$71.3M -50.1% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $112M -$8.65M -7.19% Dec 31, 2017 10-Q 2018-02-08
Q3 2017 $107M +$15K +0.01% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $136M +$81.4M +150% Jun 30, 2017 10-K 2018-08-27
Q1 2017 $142M +$95.6M +205% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $120M +$84.5M +236% Dec 31, 2016 10-Q 2017-02-09
Q3 2016 $107M +$62M +138% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $54.1M +$14.4M +36.2% Jun 30, 2016 10-K 2017-09-07
Q1 2016 $46.6M +$8.1M +21% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $35.8M -$8.45M -19.1% Dec 31, 2015 10-Q 2016-02-09
Q3 2015 $45M +$4.42M +10.9% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $39.8M +$13.4M +50.7% Jun 30, 2015 10-K 2016-08-29
Q1 2015 $38.5M +$14.1M +58.1% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $44.3M +$22.2M +100% Dec 31, 2014 10-Q 2015-02-09
Q3 2014 $40.6M +$20.3M +100% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $26.4M -$5.69M -17.7% Jun 30, 2014 10-K 2015-08-31
Q1 2014 $24.4M -$8.12M -25% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $22.1M +$841K +3.95% Dec 31, 2013 10-Q 2014-02-04
Q3 2013 $20.3M -$2.63M -11.5% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $32.1M -$3.67M -10.3% Jun 30, 2013 10-K 2014-08-29
Q1 2013 $32.5M +$1.76M +5.73% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 $21.3M +$7.15M +50.6% Dec 31, 2012 10-Q 2013-02-11
Q3 2012 $22.9M -$3.34M -12.7% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $35.8M +$17.6M +96.6% Jun 30, 2012 10-K 2013-08-29
Q1 2012 $30.7M +$14.2M +85.7% Mar 31, 2012 10-Q 2012-05-10
Q4 2011 $14.1M +$451K +3.3% Dec 31, 2011 10-Q 2012-02-07
Q3 2011 $26.2M +$10.2M +63.4% Sep 30, 2011 10-Q 2011-11-09
Q2 2011 $18.2M +$1.16M +6.84% Jun 30, 2011 10-K 2012-08-29
Q1 2011 $16.5M Mar 31, 2011 10-Q 2011-05-10
Q4 2010 $13.7M Dec 31, 2010 10-Q 2011-02-09
Q3 2010 $16.1M Sep 30, 2010 10-Q 2010-11-09
Q2 2010 $17M Jun 30, 2010 10-K 2011-08-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.